Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel Leung

Showing results (111-120 of 128) with videos related to

Pageof 13
Sort By:
Neoplasia (New York, N.Y.)|September 18, 2025
Proteomic analysis uncovers biological diversity in molecularly defined endometrial carcinomasDawn R Cochrane, Gian Luca Negri, Jutta Huvila, et al.
Human Pathology|December 18, 2020
The cutoff for estrogen and progesterone receptor expression in endometrial cancer revisited: a European Network for Individualized Treatment of Endometrial Cancer collaboration studyWillem Jan van Weelden, Casper Reijnen, Heidi V N Küsters-Vandevelde, et al.
Gynecologic Oncology|February 8, 2023
Molecular subtype stratified outcomes according to adjuvant therapy in endometrial cancerAmy Jamieson, Jutta Huvila, Samuel Leung, et al.
The Journal of Pathology|July 31, 2024
Changes in the tumour microenvironment mark the transition from serous borderline tumour to low-grade serous carcinomaRodrigo Vallejos, Almira Zhantuyakova, Gian Luca Negri, et al.
Gynecologic Oncology|March 5, 2022
Variation in practice in endometrial cancer and potential for improved care and equity through molecular classificationAmy Jamieson, Jutta Huvila, Emily F Thompson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2020
Arginine Depletion Therapy with ADI-PEG20 Limits Tumor Growth in Argininosuccinate Synthase-Deficient Ovarian Cancer, Including Small-Cell Carcinoma of the Ovary, Hypercalcemic TypeJennifer X Ji, Dawn R Cochrane, Basile Tessier-Cloutier, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2023
Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific DeathAmy Jamieson, Jutta Huvila, Derek Chiu, et al.
The Journal of Pathology|July 21, 2020
Single cell transcriptomes of normal endometrial derived organoids uncover novel cell type markers and cryptic differentiation of primary tumoursDawn R Cochrane, Kieran R Campbell, Kendall Greening, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 3, 2025
Cross-platform methylation-based site of origin classification for squamous cell carcinomasAllen W Zhang, Vahid Akbari, Andrew Galbraith, et al.
EMBO Molecular Medicine|March 12, 2021
Quantitative imaging of RAD51 expression as a marker of platinum resistance in ovarian cancerMichal M Hoppe, Patrick Jaynes, Joanna D Wardyn, et al.
Pageof 13

Showing results (111-120 of 128) with videos related to

Sort By:
Pageof 13
Neoplasia (New York, N.Y.)|September 18, 2025
Proteomic analysis uncovers biological diversity in molecularly defined endometrial carcinomasDawn R Cochrane, Gian Luca Negri, Jutta Huvila, et al.
Human Pathology|December 18, 2020
The cutoff for estrogen and progesterone receptor expression in endometrial cancer revisited: a European Network for Individualized Treatment of Endometrial Cancer collaboration studyWillem Jan van Weelden, Casper Reijnen, Heidi V N Küsters-Vandevelde, et al.
Gynecologic Oncology|February 8, 2023
Molecular subtype stratified outcomes according to adjuvant therapy in endometrial cancerAmy Jamieson, Jutta Huvila, Samuel Leung, et al.
The Journal of Pathology|July 31, 2024
Changes in the tumour microenvironment mark the transition from serous borderline tumour to low-grade serous carcinomaRodrigo Vallejos, Almira Zhantuyakova, Gian Luca Negri, et al.
Gynecologic Oncology|March 5, 2022
Variation in practice in endometrial cancer and potential for improved care and equity through molecular classificationAmy Jamieson, Jutta Huvila, Emily F Thompson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2020
Arginine Depletion Therapy with ADI-PEG20 Limits Tumor Growth in Argininosuccinate Synthase-Deficient Ovarian Cancer, Including Small-Cell Carcinoma of the Ovary, Hypercalcemic TypeJennifer X Ji, Dawn R Cochrane, Basile Tessier-Cloutier, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2023
Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific DeathAmy Jamieson, Jutta Huvila, Derek Chiu, et al.
The Journal of Pathology|July 21, 2020
Single cell transcriptomes of normal endometrial derived organoids uncover novel cell type markers and cryptic differentiation of primary tumoursDawn R Cochrane, Kieran R Campbell, Kendall Greening, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 3, 2025
Cross-platform methylation-based site of origin classification for squamous cell carcinomasAllen W Zhang, Vahid Akbari, Andrew Galbraith, et al.
EMBO Molecular Medicine|March 12, 2021
Quantitative imaging of RAD51 expression as a marker of platinum resistance in ovarian cancerMichal M Hoppe, Patrick Jaynes, Joanna D Wardyn, et al.
Pageof 13